Publication:
A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity.

dc.contributor.authorMarión, Rosa M
dc.contributor.authorStrati, Katerina
dc.contributor.authorLi, Han
dc.contributor.authorMurga, Matilde
dc.contributor.authorBlanco, Raquel
dc.contributor.authorOrtega Jimenez, Sagrario
dc.contributor.authorFernandez-Capetillo, Oscar
dc.contributor.authorSerrano, Manuel
dc.contributor.authorBlasco, MA
dc.contributor.funderAsociación Española Contra el Cáncer
dc.contributor.funderUnión Europea. Comisión Europea. European Research Council (ERC)
dc.contributor.funderComunidad de Madrid (España)
dc.contributor.funderKörber European Science Prizees_ES
dc.contributor.funderMinisterio de Ciencia e Innovación (España)
dc.date.accessioned2024-02-09T11:10:03Z
dc.date.available2024-02-09T11:10:03Z
dc.date.issued2009-08-27
dc.description.abstractThe reprogramming of differentiated cells to pluripotent cells (induced pluripotent stem (iPS) cells) is known to be an inefficient process. We recently reported that cells with short telomeres cannot be reprogrammed to iPS cells despite their normal proliferation rates, probably reflecting the existence of 'reprogramming barriers' that abort the reprogramming of cells with uncapped telomeres. Here we show that p53 (also known as Trp53 in mice and TP53 in humans) is critically involved in preventing the reprogramming of cells carrying various types of DNA damage, including short telomeres, DNA repair deficiencies, or exogenously inflicted DNA damage. Reprogramming in the presence of pre-existing, but tolerated, DNA damage is aborted by the activation of a DNA damage response and p53-dependent apoptosis. Abrogation of p53 allows efficient reprogramming in the face of DNA damage and the generation of iPS cells carrying persistent DNA damage and chromosomal aberrations. These observations indicate that during reprogramming cells increase their intolerance to different types of DNA damage and that p53 is critical in preventing the generation of human and mouse pluripotent cells from suboptimal parental cells.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipWe thank R. Serrano for mouse colony management, and M. Canamero and the Comparative Pathology Unit at the CNIO for teratoma analysis. K. S. is recipient of a contract from the Spanish Association Against Cancer (AECC). Work in the laboratory of M. A. B. is funded by grants from the MICINN (CONSOLIDER), the Regional Government of Madrid, the European Union, the European Research Council (ERC), the AECC, and the Korber European Research Award.es_ES
dc.format.number7259es_ES
dc.format.page1149es_ES
dc.format.volume460es_ES
dc.identifier.citationNature . 2009 ;460(7259):1149-53.es_ES
dc.identifier.doi10.1038/nature08287es_ES
dc.identifier.e-issn1476-4687es_ES
dc.identifier.journalNaturees_ES
dc.identifier.pmchttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624089
dc.identifier.pubmedID19668189es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/17689
dc.language.isoenges_ES
dc.publisherNature Publishing Group
dc.relation.publisherversionhttps://doi.org/10.1038/nature08287.es_ES
dc.repisalud.institucionCNIOes_ES
dc.repisalud.orgCNIOCNIO::Grupos de investigación::Grupo de Telómeros y Telomerasaes_ES
dc.repisalud.orgCNIOCNIO::Unidades técnicas::Unidad de Ratones Transgénicoses_ES
dc.repisalud.orgCNIOCNIO::Grupos de investigación::Grupo de Inestabilidad Genómicaes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.meshAnimalses_ES
dc.subject.meshApoptosises_ES
dc.subject.meshCells, Culturedes_ES
dc.subject.meshCellular Reprogramminges_ES
dc.subject.meshChromosome Aberrationses_ES
dc.subject.meshDNA Damagees_ES
dc.subject.meshDNA Repaires_ES
dc.subject.meshFemalees_ES
dc.subject.meshFibroblastses_ES
dc.subject.meshGenomic Instabilityes_ES
dc.subject.meshHumanses_ES
dc.subject.meshMalees_ES
dc.subject.meshMicees_ES
dc.subject.meshPluripotent Stem Cellses_ES
dc.subject.meshTelomerees_ES
dc.subject.meshTumor Suppressor Protein p53es_ES
dc.titleA p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity.es_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication109ab297-8df3-458e-9a03-0dd210ea8e09
relation.isAuthorOfPublicationaf015f0d-c68f-4f20-aec8-6b591b9a236e
relation.isAuthorOfPublicationeb478d8c-dd11-4b47-8795-7ac57cb60b2d
relation.isAuthorOfPublicationcbfd0012-e8e1-45cd-b6ca-3cb3b4117d6d
relation.isAuthorOfPublication.latestForDiscovery109ab297-8df3-458e-9a03-0dd210ea8e09
relation.isFunderOfPublication453a1189-9bca-4be8-8d60-695f50fe028b
relation.isFunderOfPublicationcb2ee04a-8d42-4a64-b3f6-3c156f222b35
relation.isFunderOfPublicationc87c70a3-e023-4b6b-ac25-1b2d1b483786
relation.isFunderOfPublication289dce42-6a28-4892-b0a8-c70c46cbb185
relation.isFunderOfPublication.latestForDiscovery453a1189-9bca-4be8-8d60-695f50fe028b
relation.isPublisherOfPublication301fb00e-338e-4f8c-beaa-f9d8f4fefcc0
relation.isPublisherOfPublication.latestForDiscovery301fb00e-338e-4f8c-beaa-f9d8f4fefcc0

Files